H. Wang

ORCID: 0000-0002-8708-0490
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Renal function and acid-base balance
  • Sepsis Diagnosis and Treatment
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients

Shanghai Pudong New Area Gongli Hospital
2023

Second Military Medical University
2023

Jiangxi Provincial Cancer Hospital
2019-2021

Biomarker of insulin resistance, namely triglyceride-glucose index, is potentially useful in identifying critically ill patients at high risk hospital death. However, the TyG index might have variations over time during ICU stay. Hence, purpose current research was to verify associations between dynamic change stay and all-cause mortality.The present retrospective cohort study conducted using Medical Information Mart for Intensive Care IV 2.0 (MIMIC-IV) critical care dataset, which included...

10.1186/s12933-023-01874-9 article EN cc-by Cardiovascular Diabetology 2023-06-17

Introduction: The recommended non-anthracycline (non-ANT) chemotherapy on treating Extranodal NK/T-cell lymphoma, nasal type (ENKL) is based evidences of single-arm phase I/II studies and retrospective series with limited cases short-term follow-ups. current study was to investigate treatment benefit non-ANT in comparison anthracycline (ANT) a large-scaled cohort. Methods: Patients consecutively diagnosed ENKL treated with/without radiotherapy between 2000 2015 from 20 Chinese institutes...

10.1002/hon.65_2629 article EN Hematological Oncology 2019-06-01
Coming Soon ...